$11.20
$60.44
bear $11.20
base $37.69
bull $60.44
margin of safety $21.00
market price* $40.67
Universal Corporation is the world's largest independent leaf tobacco merchant. It contracts with more than 200,000 farmers, mainly in Brazil, southern and eastern Africa, the United States and Asia, finances their crops, buys and processes the leaf, and ships it to cigarette makers. Philip Morris International (about $620 million of fiscal 2026 revenue) and Imperial Brands each account for more than 10% of sales, and six manufacturers (Altria, British American Tobacco, China Tobacco International, Imperial, Japan Tobacco and Philip Morris) together take about 60%. A smaller Ingredients segment (FruitSmart, Silva and Shank's, acquired in 2019-2021 for roughly $345 million) makes fruit, vegetable and flavor ingredients. Fiscal years end March 31. How we measured earnings. The leaf business ties up about $1.4 billion of working capital financed with seasonal bank borrowing, and the timing of crop purchases makes reported operating cash flow swing wildly (minus $75 million in fiscal 2024, plus $327 million in fiscal 2025). We remove those timing swings. We do not, however, add back inventory write-downs or provisions on farmer advances: for a leaf merchant these recur every year ($2-58 million over the past decade) and are a real cost of doing business. We also subtract the outside partners' share of earnings in partly owned subsidiaries (about $23 million in fiscal 2026), and we charge total capital spending, less a small growth allowance, as the cost of maintaining the business. That is more than the under-$30 million a year management says maintenance typically requires, so it errs on the cautious side. The $41 million fiscal 2026 goodwill write-off at Shank's is a non-cash charge on money already spent and is not deducted from earnings, but the weak ingredients record is carried in the cases below. On that basis, earnings available to shareholders were positive in every one of the last ten years, ranging from $2.57 to $5.44 per share ($3.21 in fiscal 2026). Before interest, the business generated $3.54 to $8.01 per share. We value the business before interest and then subtract its debt, using the ten-year median of about $5.90 per share as the normal level. Ten years spans a full leaf cycle: the oversupplied, weak-price years of fiscal 2018-2021 (including the 2020 shutdown) and the tight-supply, high-price years of fiscal 2023-2025. Recent results do not move that level. Fiscal 2026 business cash flow fell 24% to $6.06 per share, mostly because write-downs jumped by about $36 million, concentrated in non-wrapper dark air-cured tobacco whose carrying value has now been reset. The June 2026 quarter showed revenue down 12% and a small loss; it is a seasonally small quarter, and we treat it as a warning for the coming year rather than a new level. Debt. At March 31, 2026 Universal owed $904 million ($617 million of term loans plus $288 million of short-term lines) against $62 million of cash, but borrowing rises by up to $400 million during the South American and African buying seasons, and at June 30, 2026 net debt was about $1.01 billion. We use the average over the past year, about $930 million, and add roughly $90 million because this borrowing, much of it in local markets, costs the company around 7-7.5% a year, more than a long government bond. The total is about $1.02 billion, or $40.50 per share. The December 2025 refinancing pushed the term loans out to December 2030 ($275 million) and December 2032 ($345 million), with a $780 million revolving facility to 2030; covenants require minimum tangible net worth and limit net debt. No long-term debt matures before fiscal 2031. Base case: about $38 per share. Fiscal 2027 business cash flow of $5.30 per share, below normal because uncommitted tobacco stood at 27% of inventory in March 2026 against a target of 20% or less and the June quarter was weak; $5.70 in fiscal 2028 and the $5.90 normal level from fiscal 2029, held flat in dollars through year ten. No growth is credited: revenue growth since 2022 came from higher leaf prices and acquisitions, neither of which is a repeatable, self-funded mechanism, and the expanded Shank's plant in Lancaster, Pennsylvania has not yet earned a return. After year ten, earnings decline 3% a year indefinitely, reflecting the long decline in global cigarette volumes, which Universal's position as the leading merchant has offset for decades but cannot reverse. The business is worth about $78 per share; less $40.50 of debt, that leaves about $38. Bear case: about $11 per share. A repeat of the fiscal 2018-2021 leaf oversupply, when business cash flow ran $3.54-3.96 per share, about a third below today's normal: $4.50 in fiscal 2027, then $3.70, $3.50 and $3.80, recovering only to $4.70 because further problems in Ingredients and lost volume with one of the two largest customers are not made good, then falling 3% a year from year eight and 5% a year after year ten as cigarette volumes decline faster. Even at the trough the business earns about $88 million before interest against roughly $70 million of interest, so it carries its debt, but the dividend would not be covered. The business is worth about $52 per share; less $40.50 of debt, about $11 is left. The 2020 bankruptcy reorganization of Universal's main rival, Pyxus (formerly Alliance One), shows how leverage can overwhelm a leaf merchant in a bad cycle; Universal has entered its downturns with far stronger finances. Bull case: about $60 per share. The tight-supply conditions of fiscal 2023-2025, when business cash flow ran $6.31-8.01 per share, persist: $6.20 in fiscal 2027, $6.80 in fiscal 2028 and $7.20 a year thereafter, a level the company has already earned rather than something new, with a slower 2% annual decline after year ten. The business is worth about $101 per share; less $40.50 of debt, about $60 is left. Margin-of-safety price: $21. How sure are we of the earnings level? Moderately: ten straight years of positive earnings through a full leaf cycle, but over a wide range, and write-downs have been elevated for several years. The worst plausible outcome is a multi-year oversupply combined with the loss of a major customer. The structure would survive it: debt is long-dated, about three-quarters of tobacco inventory is normally committed to customers, and receivables are owed mainly by the world's largest tobacco companies. But the dividend would likely be cut and the shares would be worth roughly the bear value. If we are wrong about the two things we are most likely to be wrong about, that the high-price years return to the average and that the weak June 2026 quarter is temporary, and earnings settle around $5.00 per share before interest, the shares are worth about $26. The company pays $3.32 a year in dividends. At $21, the dividend alone is about 16% a year; if the business simply holds its normal level for three years, the base case implies roughly 30% a year from dividends plus value, enough cushion that a moderate disappointment still clears 20%, while the bear case implies a loss. That balance is why the margin-of-safety price is $21. What would make this wrong: a structural shift by the large manufacturers to sourcing leaf directly, a faster fall in cigarette and heated-tobacco leaf demand, or a repeat of fiscal 2026's write-downs every year. Previously published figures for this company were prepared on a different basis and are not comparable.